Rating History for GlaxoSmithKline (GSK) by Berenberg
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Kerry Holford | Upgrade | Buy (Hold) |
60.00 (54.00) |
48.13 (49.51) |
2.87% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Kerry Holford | Upgrade | Buy (Hold) |
60.00 (54.00) |
48.13 (49.51) |
2.87% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||